{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:46:05Z","timestamp":1776354365557,"version":"3.51.2"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,25]]},"DOI":"10.7759\/cureus.93185","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:05:21Z","timestamp":1758805521000},"source":"Crossref","is-referenced-by-count":2,"title":["Tumor Lysis Syndrome Triggered by Acalabrutinib in Chronic Lymphocytic Leukemia (CLL): Diagnostic and Therapeutic Implications"],"prefix":"10.7759","author":[{"given":"Monsif","family":"Fadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima Azzahra","family":"Lahlou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmine","family":"El Ouafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafsa","family":"Chahdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nouama","family":"Bouanani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a035220","article-title":"Chronic lymphocytic leukemia","volume":"11","author":"Chiorazzi N","year":"2021","unstructured":"Chiorazzi N, Chen SS, Rai KR. Chronic lymphocytic leukemia. Cold Spring Harb Perspect Med. 2021, 11:a035220. 10.1101\/cshperspect.a035220","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay J","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, et al.. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015, 136:E359-86. 10.1002\/ijc.29210","journal-title":"Int J Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9684909","article-title":"Tumor lysis syndrome in patients with hematological malignancies","volume":"2017","author":"Belay Y","year":"2017","unstructured":"Belay Y, Yirdaw K, Enawgaw B. Tumor lysis syndrome in patients with hematological malignancies. J Oncol. 2017, 2017:9684909. 10.1155\/2017\/9684909","journal-title":"J Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2004.06.014","article-title":"Acute tumor lysis syndrome: Update on therapy. (Article in French)","volume":"26","author":"Jabbour E","year":"2005","unstructured":"Jabbour E, Ribrag V. Acute tumor lysis syndrome: Update on therapy. (Article in French). Rev Med Interne. 2005, 26:27-32. 10.1016\/j.revmed.2004.06.014","journal-title":"Rev Med Interne"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0055","article-title":"Tumor lysis syndrome in chronic lymphocytic leukemia with novel targeted agents","volume":"22","author":"Cheson BD","year":"2017","unstructured":"Cheson BD, Heitner Enschede S, Cerri E, Desai M, Potluri J, Lamanna N, Tam C. Tumor lysis syndrome in chronic lymphocytic leukemia with novel targeted agents. Oncologist. 2017, 22:1283-91. 10.1634\/theoncologist.2017-0055","journal-title":"Oncologist"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2022.22075","article-title":"Clinical and economic burden of tumor lysis syndrome among patients with chronic lymphocytic leukemia\/small lymphocytic lymphoma: A real-world US retrospective study","volume":"28","author":"Rogers KA","year":"2022","unstructured":"Rogers KA, Lu X, Emond B, et al.. Clinical and economic burden of tumor lysis syndrome among patients with chronic lymphocytic leukemia\/small lymphocytic lymphoma: A real-world US retrospective study. J Manag Care Spec Pharm. 2022, 28:1033-45. 10.18553\/jmcp.2022.22075","journal-title":"J Manag Care Spec Pharm"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0904569","article-title":"The tumor lysis syndrome","volume":"364","author":"Howard SC","year":"2011","unstructured":"Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med. 2011, 364:1844-54. 10.1056\/NEJMra0904569","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2585-7","article-title":"Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: A systematic review","volume":"95","author":"Howard SC","year":"2016","unstructured":"Howard SC, Trifilio S, Gregory TK, Baxter N, McBride A. Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: A systematic review. Ann Hematol. 2016, 95:563-73. 10.1007\/s00277-015-2585-7","journal-title":"Ann Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.0177","article-title":"Guidelines for the management of pediatric and adult tumor lysis syndrome: An evidence-based review","volume":"26","author":"Coiffier B","year":"2008","unstructured":"Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: An evidence-based review. J Clin Oncol. 2008, 26:2767-78. 10.1200\/JCO.2007.15.0177","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198607243150417","article-title":"Tumor lysis syndrome after tamoxifen flare","volume":"315","author":"Cech P","year":"1986","unstructured":"Cech P, Block JB, Cone LA, Stone R. Tumor lysis syndrome after tamoxifen flare. N Engl J Med. 1986, 315:263-4. 10.1056\/NEJM198607243150417","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4081\/rt.2014.5389","article-title":"Tumor lysis syndrome in solid tumors: An up to date review of the literature","volume":"6","author":"Mirrakhimov AE","year":"2014","unstructured":"Mirrakhimov AE, Ali AM, Khan M, Barbaryan A. Tumor lysis syndrome in solid tumors: An up to date review of the literature. Rare Tumors. 2014, 6:5389. 10.4081\/rt.2014.5389","journal-title":"Rare Tumors"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcn129","article-title":"Acute spontaneous tumor lysis syndrome in a patient with squamous cell carcinoma of the lung","volume":"102","author":"Shenoy C","year":"2009","unstructured":"Shenoy C. Acute spontaneous tumor lysis syndrome in a patient with squamous cell carcinoma of the lung. QJM. 2009, 102:71-3. 10.1093\/qjmed\/hcn129","journal-title":"QJM"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.912682","article-title":"A rare case of spontaneous tumor lysis syndrome in idiopathic primary myelofibrosis","volume":"20","author":"Na YS","year":"2019","unstructured":"Na YS, Park SG. A rare case of spontaneous tumor lysis syndrome in idiopathic primary myelofibrosis. Am J Case Rep. 2019, 20:146-50. 10.12659\/AJCR.912682","journal-title":"Am J Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05094.x","article-title":"Tumour lysis syndrome: New therapeutic strategies and classification","volume":"127","author":"Cairo MS","year":"2004","unstructured":"Cairo MS, Bishop M. Tumour lysis syndrome: New therapeutic strategies and classification. Br J Haematol. 2004, 127:3-11. 10.1111\/j.1365-2141.2004.05094.x","journal-title":"Br J Haematol"},{"key":"ref15","article-title":"Etiology and management of tumor lysis syndrome in patients with chronic lymphocytic leukemia","volume":"7","author":"Cheson BD","year":"2009","unstructured":"Cheson BD. Etiology and management of tumor lysis syndrome in patients with chronic lymphocytic leukemia. Clin Adv Hematol Oncol. 2009, 7:263-71.","journal-title":"Clin Adv Hematol Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.221433-f","article-title":"Syndrome de lyse tumorale","volume":"195","author":"Grewal K","year":"2023","unstructured":"Grewal K, Herrity E, Pasic I. Syndrome de lyse tumorale. CMAJ. 2023, 195:E969-70. 10.1503\/cmaj.221433-f","journal-title":"CMAJ"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5222\/MMJ.2021.56424","article-title":"A rare side effect of ibrutinib: Tumor lysis syndrome","volume":"36","author":"Ozturk E","year":"2021","unstructured":"Ozturk E, Erdogan Ozunal I. A rare side effect of ibrutinib: Tumor lysis syndrome. Medeni Med J. 2021, 36:176-9. 10.5222\/MMJ.2021.56424","journal-title":"Medeni Med J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/406397-tumor-lysis-syndrome-triggered-by-acalabrutinib-in-chronic-lymphocytic-leukemia-cll-diagnostic-and-therapeutic-implications","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:05:22Z","timestamp":1758805522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/406397-tumor-lysis-syndrome-triggered-by-acalabrutinib-in-chronic-lymphocytic-leukemia-cll-diagnostic-and-therapeutic-implications"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.93185","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,25]]}}}